Benzodiazepine Use and Misuse Among Adults in the United States
Open accessThe DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Goals were to determine the prevalence of benzodiazepine use (as prescribed and misuse), characterize misuse, and examine variation by age. METHODS: A cross-sectional analysis was conducted of 2015 and 2016 National Survey on Drug Use and Health data limited to adults ≥18 (N=86,186) and data from those respondents reporting benzodiazepine use (N=10,290). Measurements included past-year prescription benzodiazepine use and misuse ("any way a doctor did not direct"), substance use disorders, mental illness, and demographic characteristics. Misuse was compared between younger (18-49) and older (≥50) adults. RESULTS: A total of 30.6 million adults (12.6%) reported past-year benzodiazepine use-25.3 million (10.4%) as prescribed and 5.3 million (2.2%) misuse. Misuse accounted for 17.2% of overall use. Adults ages 50-64 had the highest prescribed use (12.9%). Those ages 18-25 had the highest misuse (5.2%), and those ages ≥65 had the lowest (.6%). Misuse and abuse of or dependence on prescription opioids or stimulants were strongly associated with benzodiazepine misuse. Benzodiazepine misuse without a prescription was the most common type of misuse, and a friend or relative was the most common source. Adults ages ≥50 were more likely than younger adults to use a benzodiazepine more often than prescribed and to use a benzodiazepine to help with sleep. CONCLUSIONS: Benzodiazepine use among U.S. adults was higher than previously reported, and misuse accounted for nearly 20% of use overall. Use by adults ages 50-64 now exceeds use by those ages ≥65. Patients also prescribed stimulants or opioids should be monitored for benzodiazepine misuse. Improved access to behavioral interventions for sleep or anxiety may reduce some misuse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Since benzodiazepines are among the most frequently prescribed drugs in the United States, treatments for BIND represent an urgent unmet medical need [25].”
From Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey (2023) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03923.x · Cited by 2,578
Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2016) · Annals of Internal Medicine · doi:10.7326/m15-2175 · Cited by 1,965 · cited 1×
“A significant proportion of the NSDUH-defined “misuse”, therefore, could reflect use for untreated symptoms among those with poor access to care—specifically behavioral treatments for insomnia (31, 32) or anxiety disorders (33, 34).”
BackgroundMeta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons
Woolcott, J. C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.357 · Cited by 1,326 · cited 1×
“While use among those ≥65 has not been declining (1, 3), the decades of evidence regarding safety concerns (4, 7, 27) and professional guidelines (6, 28) recommending limited use in older adults may have helped slow growth.”
BackgroundExplicit Criteria for Determining Potentially Inappropriate Medication Use by the Elderly: An Update
Beers, M. H. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440350031003 · Cited by 1,059 · cited 1×
“While use among those ≥65 has not been declining (1, 3), the decades of evidence regarding safety concerns (4, 7, 27) and professional guidelines (6, 28) recommending limited use in older adults may have helped slow growth.”
BackgroundBenzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676 · cited 1×
“A significant proportion of the NSDUH-defined “misuse”, therefore, could reflect use for untreated symptoms among those with poor access to care—specifically behavioral treatments for insomnia (31, 32) or anxiety disorders (33, 34).”
BackgroundPark, T. W., Saitz, R., Ganoczy, D., Ilgen, M. A., & Bohnert, A. S. B. (2015) · BMJ · doi:10.1136/bmj.h2698 · Cited by 579
Help-seeking behaviour in men and women with common mental health problems: cross-sectional study
Oliver, M. I., Pearson, N., Coe, N., & Gunnell, D. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.186.4.297 · Cited by 558 · cited 1×
“This may further support the hypothesis that higher misuse is partially a function of limited access to a prescribed option—limited for younger patients due to lack of insurance and for men due to minimal disclosure of mental health concerns to providers (42).”
BackgroundBenzodiazepines of Long and Short Elimination Half-life and the Risk of Hip Fracture
Ray, W. A. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430230088031 · Cited by 548 · cited 1×
“While use among those ≥65 has not been declining (1, 3), the decades of evidence regarding safety concerns (4, 7, 27) and professional guidelines (6, 28) recommending limited use in older adults may have helped slow growth.”
Background
Research works printed but not linked: 2
- Lipari RN, Williams M, Van Horn SL. Why Do Adults Misuse Prescription Drugs? 2017 7 27 In: The Center for Behavioral Health Statistics and Quality Report. Rockville (MD): Substance Abuse and Mental Health Services Administration (US) Available from: https://www.ncbi.nlm.nih.gov/books/NBK458284/ 28968046
- Center for Behavioral Health Statistics and Quality. (2016). 2015 National Survey on Drug Use and Health: Summary of the Effects of the 2015 NSDUH Questionnaire Redesign: Implications for Data Users. Substance Abuse and Mental Health Services Administration, Rockville, MD. 30199192
Cited by
Items 101–200 of 351
McHugh, R. K., Votaw, V. R., McCarthy, M. D., Bichon, J. A., Bailey, A. J., & Fitzmaurice, G. M. (2022) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001115 · Cited by 8
Niznik, J. D., Hughes, T. D., Armistead, L. T., Kashyap, J., Roller, J., Busby‐Whitehead, J., & Ferreri, S. P. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18288 · Cited by 8
Huang, Y., Tang, I., Chin, W., Jang, L., Lee, C., Lin, C., Yang, C., & Cho, S.-L. (2022) · Nature and Science of Sleep · doi:10.2147/nss.s346941 · Cited by 8
“Previous studies have indicated that up to 13% of US adults have reported benzodiazepine use in the last year.(11) The outpatient use of benzodiazepines has also increased significantly.”
BackgroundNogueira, A. F., & Nunes, B. (2020) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2020.103538 · Cited by 8
Zhang, H., Wu, Y., Qiu, M., Zheng, Y., Chen, L., Shi, X., Yang, J., Lin, Q., & Lin, J. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105345 · Cited by 7
Timko, C., Hoggatt, K. J., Esmaeili, A., Lewis, E. T., Lor, M. C., Maust, D. T., & Nevedal, A. (2022) · Psychiatric Services · doi:10.1176/appi.ps.202100617 · Cited by 7
Self-citationEvaluation of a tactile breath pacer for sleep problems: A mixed method pilot study
Vermeylen, S., Honinx, E., Broes, S., Vandenhoudt, H., & Witte, N. A. J. D. (2022) · Frontiers in Digital Health · doi:10.3389/fdgth.2022.908159 · Cited by 7
“Today, overconsumption of prescription medication is reported (25).”
BackgroundTruedson, P., Ott, M., Wahlström, L., Lundqvist, R., Maripuu, M., Lindmark, K., Lieber, I., & Werneke, U. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1358461 · Cited by 7
“This compared to 22% benzodiazepine use in individuals with mild mental illness, 29% with moderate mental illness, and 42% with severe mental illness (53).”
BackgroundLieber, S. R., Jones, A. R., Jiang, Y., Gowda, P., Patel, M. S., Lippe, B., Shenoy, A., Evon, D. M., Gurley, T., Ngo, V., et al. (2024) · Liver Transplantation · doi:10.1097/lvt.0000000000000390 · Cited by 9
“A previous study reported that 12.6% of US adults received a benzodiazepine prescription, [42] suggesting that use among commercially insured LTRs may be higher than the general population.”
Influential[Factors associated with benzodiazepines dependence in insomnia patients]
Maravillas-Estrada, A., Roy-García, I. A., Rivas-Ruíz, R., & Vilchis-Chaparro, E. (2023) · Revista Médica del Instituto Mexicano del Seguro Social · doi:10.5281/zenodo.8319759 · Cited by 9
McCabe, S. E., Schulenberg, J. E., Wilens, T. E., Schepis, T. S., Werner, K. S., McCabe, V. V., & Veliz, P. T. (2024) · Psychiatric Services · doi:10.1176/appi.ps.20230418 · Cited by 8
Reconsidering Benzodiazepines and Z-Drug Prescriptions: Responsible Prescribing and Deprescribing
McGee, N., Proctor, J., Hart, A. M., & Burman, M. E. (2020) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2020.08.004 · Cited by 8
Lui, L. M. W., Lee, Y. L., Lipsitz, O., Rodrigues, N. B., Gill, H., Ma, J., Wilkialis, L., Tamura, J. K., Siegel, A. N., Chen-Li, D. C. J., et al. (2021) · CNS Spectrums · doi:10.1017/s1092852921000055 · Cited by 8
Lee, J., Salloum, R. G., Lindstrom, K., & McHugh, R. K. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.107058 · Cited by 7
Depression and Anxiety Disorders
Karamustafalıoğlu, O., & Yumrukçal, H. (2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg003.pub2 · Cited by 8
Benefits and Liabilities of Benzodiazepines and Z-Drugs: What We Know and What We Don’t Know
Silberman, E. K. (2025) · Drugs · doi:10.1007/s40265-025-02261-2 · Cited by 8
“Rather, deviations from clinicians’ instructions represent patients’ attempts to better mitigate their symptoms and distress [59, 60].”
Weleff, J., Anand, A., Squeri, M., Sieke, R., Thompson, N. R., & Barnett, B. S. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2191610 · Cited by 9
“In 2015 and 2016, 13% of Americans reported past-year benzodiazepine use, with misuse accounting for 20% of benzodiazepine use (Maust, Lin, and Blow 2018).”
BackgroundBushnell, G., Rynn, M. A., Gerhard, T., Keyes, K. M., Hasin, D. S., Cerdá, M., Nyandege, A. N., & Olfson, M. (2023) · Addiction · doi:10.1111/add.16359 · Cited by 6
Factors associated with hypnotics polypharmacy in the Japanese population
Shimura, A., Takaesu, Y., Sugiura, K., Takagi, S., Okawa, Y., & Inoue, Y. (2024) · Sleep Medicine · doi:10.1016/j.sleep.2024.08.006 · Cited by 6
Evaluation of a Benzodiazepine Immunoassay for Urine Drug Testing in Clinical Specimens
Ge, M., Alabi, A., Kelner, M. J., Fitzgerald, R. L., & Suhandynata, R. T. (2024) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfae083 · Cited by 6
Krieger, A. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1569416 · Cited by 7
Substance Use and Misuse Among Older Adults: A Scoping Review
Alhalaseh, L., Abushams, L., Qudah, R., Hout, M. C. V., & Wazaify, M. (2025) · Substance Use & Misuse · doi:10.1080/10826084.2025.2513525 · Cited by 6
“%) observed among those aged 65 and older (Maust et al., 2019).”
Curado, D. F., de Barros, V. V., Opaleye, E. S., & Noto, A. R. (2020) · Trends in Psychiatry and Psychotherapy · doi:10.1590/2237-6089-2019-0049 · Cited by 6
Prevalence of Substance Abuse Among Trauma Patients in Rural West Virginia
Mansoor, K., Gonçalves, B. D. S., Lakhani, H. V., Tashani, M., Jones, S. E., Sodhi, K., Thompson, E. A., & Dougherty, T. J. (2023) · Cureus · doi:10.7759/cureus.36468 · Cited by 10
Haider, M. R., & Jayawardhana, J. (2023) · American Journal on Addictions · doi:10.1111/ajad.13481 · Cited by 7
Manaloto, F. R., Meneses, V. M., & Mata, D. C. (2022) · Journal of Analytical Toxicology · doi:10.1093/jat/bkac012 · Cited by 6
Nguyen, T. P. P., Soprano, S. E., Hennessy, S., Brensinger, C. M., Bilker, W. B., Miano, T. A., Acton, E. K., Horn, J. R., Chung, S. P., Dublin, S., et al. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.04.033 · Cited by 6
Benzodiazepine exposures among women of reproductive age in the US, 2004–2018
Michaels, N. L., Spiller, H., Badeti, J., Sheftall, A., Funk, A., & Smith, G. A. (2021) · Human & Experimental Toxicology · doi:10.1177/09603271211013431 · Cited by 9
“Reasons for benzodiazepine misuse include to aid in relaxation, relieve tension, or help with sleep.(4) Individuals who take benzodiazepines without a prescription often receive the drugs from a friend or relative.”
BackgroundInfluentialThe effect of benzodiazepines on exercise in healthy adult participants: A systematic review
Holgado, D., Manresa‐Rocamora, A., Zamboni, L., Lugoboni, F., Peiró, A. M., & Zandonai, T. (2021) · Journal of Addictive Diseases · doi:10.1080/10550887.2021.1990640 · Cited by 7
Use of Pharmacogenetics for Benzodiazepine Prescription: State of the Art and Expectations
Zubiaur, P., & Abad‐Santos, F. (2022) · Pharmacogenomics · doi:10.2217/pgs-2022-0161 · Cited by 6
Damiri, B., Mousa, A., & Helou, M. (2023) · BMJ Public Health · doi:10.1136/bmjph-2023-000537 · Cited by 5
“Despite these limitations, this study is the first to identify the associated risk factors with ATS use among Palestinians.”
Barbaux, L., Cross, N. E., Perrault, A. A., Essounni, M., Desrosiers, C., Clerc, D., Andriamampionona, F., Lussier, D., Tannenbaum, C., Guimond, A., et al. (2025) · Sleep Medicine · doi:10.1016/j.sleep.2025.106826 · Cited by 5
Differentiation of Therapeutic and Illicit Drug Use via Metabolite Profiling
Stoeva, S., Hvarchanova, N., Gancheva, S., Eftimov, M., Georgiev, K., & Radeva-Ilieva, M. P. (2025) · Metabolites · doi:10.3390/metabo15110745 · Cited by 7
Martínez-León, M. A., Carballo, J. L., & Pérez‐Jover, V. (2023) · PubMed Central · Cited by 7
Intentional benzodiazepine poisoning in older adults reported to United States Poison Centers
Choi, N. G., Choi, B. Y., Marti, C. N., & Baker, D. (2024) · Clinical Toxicology · doi:10.1080/15563650.2024.2334828 · Cited by 5
“Research has shown that adults aged 50 and older are more likely than younger adults to misuse benzodiazepines (defined as using more often than prescribed), and that benzodiazepine misuse is strongly associated with comorbidity and polypharmacy, especially involving prescription opioids [10,16].”
BackgroundTreating Benzodiazepine Withdrawal in a Bridge Clinic
Laks, J., Kim, T. W., Christine, P. J., Evans, J. C., Farrell, N. M., Kehoe, J., Younkin, M., & Taylor, J. L. (2024) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001334 · Cited by 5
Särkilä, H., Taipale, H. T., Tanskanen, A. J., Kurko, T., Taiminen, T. J., Tiihonen, J., Sund, R., Saastamoinen, L., Hietala, J. A., & Niemelä, S. (2024) · BJPsych Open · doi:10.1192/bjo.2024.780 · Cited by 6
Choi, N. G., Choi, B. Y., Marti, C. N., & Baker, D. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1505040 · Cited by 6
Khan, S. M., Kasagga, A., Verma, A., Saraya, E., Haque, M. S., Senaratne, M., & Khan, S. (2025) · Cureus · doi:10.7759/cureus.84318 · Cited by 7
“%) engage in misuse [11].”
Struble, C. A., Thomas, K. F., Stenersen, M. R., Moore, K., Burke, C., Pittman, B., & McKee, S. (2022) · American Journal on Addictions · doi:10.1111/ajad.13258 · Cited by 4
Carrasco‐Garrido, P., Jiménez‐Trujillo, I., Hernández‐Barrera, V., Florêncio, L. L., & Palacios‐Ceña, D. (2020) · Journal of Substance Use · doi:10.1080/14659891.2020.1800846 · Cited by 7
“Inappropriate use of these drugs is one of the most prevalent and consequential forms of prescription drug misuse, reaching values of 7.7% in such countries as the United Kingdom (Kapil et al., 2014)10, a figure comparable to data for North America (Maust et al., 2019).”
BackgroundResultInfluentialPrevalence and socioeconomic factors in the prescription of concurrent amphetamine and alprazolam
Zarkowski, P. A., Van-Den-Ende, A. R., & Groen, J. A. (2020) · The International Journal of Psychiatry in Medicine · doi:10.1177/0091217420960619 · Cited by 5
“As income increases, use of benzodiazepines decreases.(21) This pattern mirrors the overall declining prevalence of indications for benzodiazepines, including anxiety disorders, with greater income.”
BackgroundBorrelli, E. P., Morphis, B., Youssef, R., Chambers, L. C., Hallowell, B. D., Bratberg, J. P., & Kogut, S. J. (2020) · PubMed · Cited by 5
Opioid use disorder and concurrent benzodiazepine use: clinical risks and management strategies
Fakhri, A., Ritvo, A. D., Casarella, J., & Tang, Y. (2025) · Journal of Addictive Diseases · doi:10.1080/10550887.2025.2593244 · Cited by 4
Intoxicaciones por benzodiacepinas y antidepresivos, una realidad preocupante
Rojas, J. P. C., & Müller-Ramírez, C. (2023) · Revista médica de Chile · doi:10.4067/s0034-98872023000400453 · Cited by 5
Raji, M. A., Shah, R., Westra, J. R., & Kuo, Y. (2024) · Pain · doi:10.1097/j.pain.0000000000003331 · Cited by 4
Expecting medication misuse: a proactive approach to drug discovery to prevent fatal overdose
Carry, E., Vasilatis, A., Johnson, A. L., & Ryan, J. W. (2025) · Future Medicinal Chemistry · doi:10.1080/17568919.2025.2476388 · Cited by 4
“Approximately one-half of the US adult population is prescribed at least one prescription medication [5], 6.4% are prescribed prescription opioids [6], and 12.6% are prescribed BZD [7].”
InfluentialAnxiolytics and Sedative-Hypnotics Toxicity
Simone, C., & Bobrin, B. D. (2020) · StatPearls · Cited by 4
Thornton, S. L., Whitacre, J., Pallo, N., Roberts, N. B., & Oller, L. (2021) · Kansas Journal of Medicine · doi:10.17161/kjm.vol1414653 · Cited by 4
Maust, D. T., Bohnert, A. S. B., Strominger, J., & Goldstick, J. E. (2023) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-023-00674-x · Cited by 4
“While these OD deaths are not attributable to BZD alone, factors associated with OD risk among those prescribed BZD are critical to understand given how widely prescribed BZD are [31] and their well-established association with increased OD risk [32–35].”
BackgroundSelf-citationOlani, A. B., & Decorte, T. (2023) · Harm Reduction Journal · doi:10.1186/s12954-023-00890-y · Cited by 6
“Nevertheless, the (ab)use of sed-atives, which is widely employed to treat sleep disorder after the use of other stimulant substances [55, 56], is not reported in connection with khat chewing.”
BackgroundDose–response association of benzodiazepine use and development of deep vein thrombosis
Shih, N.-C., Yeh, L., Wang, B.-Y., Yang, S., Yang, S.-F., & Yeh, C. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115553 · Cited by 4
Exploring trends in benzodiazepine-positive fatal drug overdoses in Tennessee, 2019–2021
Moses, J., Korona-Bailey, J., & Mukhopadhyay, S. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2287194 · Cited by 4
Prescribing benzodiazepines in young adults with anxiety: a qualitative study of GP perspectives
Archer, C., Wiles, N., Kessler, D. S., Chew-Graham, C. A., & Turner, K. M. (2024) · British Journal of General Practice · doi:10.3399/bjgp.2024.0211 · Cited by 5
“11 Historically, benzodiazepines were often prescribed for anxiety.”
BackgroundTian, F., Chen, Z., Zhang, J., Zhang, Y., & Feng, Q. (2025) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-025-00378-x · Cited by 4
“Moreover, medications like antihypertensives may need dosage adjustments due to altered tolerance in colder weather, further exacerbating the risk of PIP [23].”
Votaw, V. R., Trapani, E. W., Geyer, R. B., Sugarman, D. E., & McHugh, R. K. (2025) · Substance Use & Misuse · doi:10.1080/10826084.2025.2496936 · Cited by 4
“Misuse for recreational reasons (e.g., to get high) has also been reported in the general population (Maust et al., 2019; McHugh et al., 2023), college students (Brandt et al., 2014), and those with SUDs (Chen et al., 2011; Stein et al., 2016).”
Chapman, C. A., Povysheva, N. V., Tarr, T. B., Nuwer, J. L., Meriney, S. D., Johnson, J. W., & Jacob, T. C. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1624813 · Cited by 4
Suss, T., & Oldani, M. J. (2020) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20191218-05 · Cited by 5
Lima, A. E., de Moura, L. C., Gomides, Y. J. B., Paes, J. F., & de Lima, R. Q. (2021) · Research Society and Development · doi:10.33448/rsd-v10i15.22886 · Cited by 7
Prevalence and Correlates of Prescription Drug Misuse in a Nationwide Population Survey in Taiwan
Liu, S., Wu, C., Lee, M., Huang, M.-C., Chan, C., & Chen, C. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182412961 · Cited by 4
da Silva, C. A., Marques, D. A., Patrone, L. G. A., Biancardi, V., Bícego, K. C., & Gargaglioni, L. H. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.137014 · Cited by 4
Kralj-Vasilj, M., Šolić, K., & Lovrić, R. (2023) · Healthcare · doi:10.3390/healthcare11212908 · Cited by 5
“Other studies report excessive and irrational consumption of these medications and insufficient control by physicians [54,55].”
BackgroundBenzodiazepine and Z-hypnotic stewardship
Wright, S. L. (2022) · The Journal of Family Practice · doi:10.12788/jfp.0381 · Cited by 3
Assessing the safety of midazolam: A comprehensive analysis of adverse events from FAERS
Chen, J., Wang, Z., Li, W., & Mao, S. (2025) · Toxicology in Vitro · doi:10.1016/j.tiv.2025.106023 · Cited by 3
Chirica, M. G., Adams, S. M., Quinn, P. D., Meraz, R., Rickert, M. E., Sidorchuk, A., Kroenke, K., & D'Onofrio, B. M. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.02.065 · Cited by 3
Sankaranarayanan, M., Donahue, M. A., Sun, S., Brooks, J. D., Schwamm, L. H., Newhouse, J. P., Hsu, J. T.-A., Blacker, D., Haneuse, S., & Moura, L. M. V. R. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70194 · Cited by 3
Delivery models to improve adherence to medicines for chronic diseases in primary care
Diaz, R., Satheesh, G., Moran, A. E., Perel, P., Rodgers, A., & Schutte, A. E. (2025) · The Lancet Primary Care · doi:10.1016/j.lanprc.2025.100074 · Cited by 5
Benzodiazepine prescribing patterns among Medicare providers, 2017 to 2023
Silvernail, O., Ritvo, A. D., Silvernail, B., & Martin, P. R. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1723651 · Cited by 3
“However, as noted by Maust et al. in 2018, “within primary care, the links between geographic or prescriber characteristics and BZD prescribing have been subject to little research” (10, 11, 16–18).”
Qin, P., Li, F., Li, X., & Feng, X. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1772542 · Cited by 4
“…the adverse effects of psychotropic medications, including the risk of falls, polypharmacy interactions, and cognitive blunting associated with prolonged use of antidepressants and benzodiazepines, prioritizing robust non-pharmacological interventions is of paramount clinical importance (106, 107).”
Central nervous system medication use around hospitalization
Pavon, J. M., Sloane, R. J., Colon-Emeric, C. S., Pieper, C. F., Schmader, K. E., Gallagher, D. M., & Hastings, S. N. (2024) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18915 · Cited by 3
“28,29 Identifying the transition point, such as from hospital discharge to out-patient care, when the likelihood of transitioning to a riskier CNS medication profile is highest, can inform systematic approaches to address this trend.”
BackgroundLong-term benzodiazepine prescriptions in community psychiatry clinics
Tau, M. A., Moosa, M. Y. H., & Jeenah, F. Y. (2024) · South African Journal of Psychiatry · doi:10.4102/sajpsychiatry.v30i0.2181 · Cited by 3
“15 In addition, there may have been inadequate monitoring of prescriptions by pharmacists, who are required to serve as gatekeepers.”
BackgroundAllary, A., Proulx-Tremblay, V., Bélanger, C., Hudon, C., O’Connor, K. P., Roberge, P., Vasiliadis, H., Desrosiers, C., Cruz-Santiago, D., & Grenier, S. (2024) · Aging & Mental Health · doi:10.1080/13607863.2024.2372473 · Cited by 3
“In 2015– 2016, an estimated 30.6 million people (12.6% of adults) reported past-year use (Maust et al., 2019).”
InfluentialChapter 20. Neurobiology and Treatment of Sedative-, Hypnotic-, and Anxiolytic-Related Disorders
Jones, J. L., VandenBerg, A., & Malcolm, R. J. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb20 · Cited by 3
Hirschtritt, M. E., Avalos, L. A., Sarovar, V., Ridout, K. K., Goler, N. C., Ansley, D. R., Satre, D. D., & Young‐Wolff, K. C. (2022) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000946 · Cited by 3
The effects of becoming a physician on prescription drug use and mental health treatment
Anderson, D. M., Diris, R., Montizaan, R. M., & Rees, D. I. (2023) · Journal of Health Economics · doi:10.1016/j.jhealeco.2023.102774 · Cited by 5
Tarhini, Z., Magné, J., Preux, P., Parenté, A., Mathonnet, M., Christou, N., & Jost, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115950 · Cited by 3
Kiselev, N., Amsler, S., Boumparis, N., Dey, M., Wenger, A., Schnoz, D., Bachmann, A., Schaub, M. P., & Gross, C. S. (2024) · Swiss Medical Weekly · doi:10.57187/s.3895 · Cited by 3
Jackson, N. A., Gan, T., Davenport, D. L., Oyler, D. R., Ebbitt, L. M., Evers, B. M., & Bhakta, A. S. (2020) · Surgical Endoscopy · doi:10.1007/s00464-020-08062-w · Cited by 4
Miranda, C. C., Azevedo, G. Z., Moreira, B. R., Pesca, J. P. M., Destefani, B. P., Rizzi, L., Amorim, A. D., & Ferreira, F. B. (2020) · Arquivos Médicos dos Hospitais e da Faculdade de Ciências Médicas da Santa Casa de São Paulo · doi:10.26432/1809-3019.2020.65.033 · Cited by 3
New Findings Related to Cognition, Intellectual Disability, Dementia, and Autism
Kalin, N. H. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20040405 · Cited by 3
Benzodiazepines: Pharmacology Up-to-Date and Practical Issues
Kang, U. G., Kim, S. H., Lee, N. Y., Lee, K. Y., Kim, Y. S., & Chung, I. W. (2023) · 신경정신의학 · doi:10.4306/jknpa.2023.62.1.1 · Cited by 2
Zhou, Z., Yang, B., Fu, H., Qu, X., Sun, P., Feng, Y., & Ying, G. (2025) · Water Research · doi:10.1016/j.watres.2025.124701 · Cited by 3
Vyas, A., Patry, E. J., Owens, N. J., Belviso, N., & Kogut, S. J. (2019) · Drugs - Real World Outcomes · doi:10.1007/s40801-019-00162-x · Cited by 2
Carvalho-Silva, L., Jiménez‐Correa, U., Santana-Miranda, R., Heyerdahl-Viau, I., Benitez-Morales, J., García-Casas, M., & Martínez-Núñez, J. M. (2024) · Pharmacy · doi:10.3390/pharmacy12020056 · Cited by 2
“One report suggests that doctors should recognize their role as a potential source of benzodiazepines destined for misuse [46].”
BackgroundTesting Strategies and the Emergence of Designer Benzodiazepines
Bazydlo, L. A. L., & Larkey, N. E. (2025) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2025.01.013 · Cited by 2
McBride, A., Henning, O. J., Landmark, C. J., Watkins, L. V., Tromans, S. J., Basset, P., Triantafyllopoulou, P., & Shankar, R. (2025) · Epilepsia Open · doi:10.1002/epi4.70145 · Cited by 2
de la Villarmois, E. A., & Pérez, M. F. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14515 · Cited by 2
Wilson, T. D., Barry, K. L., Maust, D. T., & Blow, F. C. (2020) · Aging & Mental Health · doi:10.1080/13607863.2020.1727850 · Cited by 3
“Previous research has found that among adults aged 50 and older, the main reasons for misusing benzodiazepines consisted of relaxation/relieving tension, to help with sleep, to get high, or to help with feelings or emotions (Maust et al., 2019).”
BackgroundSelf-citationLi, M., Lv, G., Lee, T.-Y., Wu, J., & Lu, K. (2020) · AIDS Care · doi:10.1080/09540121.2020.1842320 · Cited by 2
“(Vinkers & Olivier, 2012) The utilization rate of benzo-diazepines was 12% in 2016 and increased over time in the U.S. (Blanco et al., 2018; Maust et al., 2019) Given the short-term bene fi ts and long-term risks, benzo-diazepines should be used with caution and are an important medication class for…”
BackgroundThe Characteristics of Benzodiazepine Prescribing in the Republic of Srpska, Bosnia and Herzegovina
Maksimović, Ž., Stajić, M., Stojiljković, M. P., Šatara, S. S., Stojaković, N., & Škrbić, R. (2022) · Medicina · doi:10.3390/medicina58080980 · Cited by 2
Use of anxiolytics and hypnotic drugs during COVID-19 pandemic: The literature review
Trajkovski, T., & Marić, N. P. (2022) · Medicinski podmladak · doi:10.5937/mp73-35916 · Cited by 2
“Also, BZD is typically co-abused with other substances, especially opioids (39).”
BackgroundPonton, R., Gear, G., Hadiyounzadeh, P., Iqram, F., Kim, A., Out, S., Thoo, W. E., Sheridan, J. L., & Newcombe, D. A. L. (2023) · Journal of Consumer Health on the Internet · doi:10.1080/15398285.2023.2166269 · Cited by 2
“…2.2% of a nationally representative sample of adults in the United States self-reported misusing BZDs in the previous year, with “ misuse without a prescription, ” as the most common type of misuse; friends or family were the most common sources of BZDs in this study (Maust, Lin, and Blow 2019).”
BackgroundInfluentialLiang, Z., Chihuri, S. T., Andrews, H., Betz, M. E., DiGuiseppi, C. G., Eby, D. W., Hill, L. L., Jones, V., Mielenz, T. J., Molnar, L. J., et al. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18544 · Cited by 3
Takamine, L. H., Krein, S. L., Ratliff, E., Strominger, J., Virk, A., & Maust, D. T. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-023-08385-z · Cited by 3
Self-citationCannabis use associated with high-risk drug use among Palestinians: An emerging health risk
Damiri, B., Bilbeisi, S., MohammedAli, M., & Najjar, M. (2024) · Population Medicine · doi:10.18332/popmed/180979 · Cited by 2
Kyei, E. F., & Zhang, L. (2024) · Policy Politics & Nursing Practice · doi:10.1177/15271544241232588 · Cited by 2
“The oldest age group (50 – 64) had the highest prevalence of substance use history, indicating potential generational differences in substance use patterns or longevity of use (Maust et al., 2018).”
BackgroundHeeg, J., Stratmann, M. W., Dirmaier, J., Härter, M. C., Kriston, L., Lindemann, C., & Verthein, U. (2024) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-024-01396-9 · Cited by 2
“Various countries have been dealing with a high prevalence of BZD and ZD use for many years (Maust et al., 2019; Weymann et al., 2017; Woods et al., 2022).”
Rodríguez‐Ruiz, J., Miller, B. L., Espejo‐Siles, R., & Marín‐López, I. (2024) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2024.2444893 · Cited by 2
“This is contrary to previous studies reporting more frequency of benzodiazepine misuse than prescription use in young adults (Maust, Lin, and Blow 2019; Tam, Benotsch, and Li 2020).”
Saniotis, A., Henneberg, M., & Mohammadi, K. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1558625 · Cited by 2
Screening accuracy of the German version of the benzodiazepine self-report questionnaire
Stratmann, M. W., Heeg, J., Härter, M. C., Kriston, L., Verthein, U., & Lindemann, C. (2025) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2025.152607 · Cited by 3
Metadata
- Authors
- Maust, D. T., Lin, L. A., & Blow, F. C.
- Affiliations
- University of Michigan (US)
- Venue
- Psychiatric Services
- Published
- 2019-02-01
- Volume
- 70
- Issue
- 2
- Pages
- 97-106
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- PMC
- PMC6358464
- OpenAlex
- W2904755589
- Cited by
- 337
- References
- 42
- Citations by year
- 2026: 40 · 2025: 50 · 2024: 72 · 2023: 48 · 2022: 56 · 2021: 27 · 2020: 35 · 2019: 8
- FWCI
- 16.69
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Psychiatric Services (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01DA045705)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- benzodiazepine misuse, benzodiazepine use, prescription drug misuse, prevalence, age differences, substance use disorders, opioid misuse, stimulant abuse, sleep aids, benzodiazepine dependence, National Survey on Drug Use and Health
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Benzodiazepines, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Drug Prescriptions, United States, Prevalence, Young Adult, Prescription Drug Misuse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.